Physician Education: Bridging Clinical Research and Patient Care

Update on New Biobehavioral Approaches to HIV Prevention

Thursday, September 1, 2016

1:00 PM (ET), 12:00 PM (CT), 11:00 AM (MT), 10:00 AM (PT)

Overview

Assessment of Needs

The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians. The use of emtricitabine and tenofovir disoproxil fumarate as preexposure prophylaxis (PrEP) to prevent HIV acquisition in men and women who demonstrate at-risk behaviors has been approved by the Centers for Disease Control and Prevention and the US Food and Drug Administration for several years. However, uptake has been limited in some quarters because of concerns about behavioral disinhibition, selection for drug resistance, and drug-related toxic effects in otherwise healthy people. This webinar will review recent data from PrEP clinical trials and demonstration projects presented at recent research conferences, including the 21st International AIDS Conference in Durban, South Africa, held from July 18 to July 22, 2016. The presentation will highlight evidence for the optimal use of PrEP as part of a comprehensive prevention package and best practices in PrEP screening and delivery. The presentation will also discuss investigational HIV prevention modalities in current clinical trials, including injectable and topical antiretroviral treatments, and infusible monoclonal antibodies.

Learning Objectives

At the conclusion of this webinar, participants will be able to:

  • Describe new data on the use of antiretroviral drugs for HIV prevention, HIV vaccines, and immunoprophylaxis.
  • Describe the current status of the uptake of oral preexposure prophylaxis (PrEP).
  • Apply best practices in clinical assessment and monitoring of patients using antiretroviral approaches for prevention of HIV infection.

Registration

Who Should Attend

This webinar is designed for physicians who are actively treating or will be treating patients with HIV infection.

This activity is also relevant for other practitioners, including nurse practitioners and other nursing professionals, physician assistants, and pharmacists.

Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.

Registration closes on Wednesday, August 31, 2016, 4:00 PM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at registration“at”iasusa.org or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits

Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 1.5 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

Pharmacy Credits

Accreditation Council for Pharmacy Education logoEducational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.5 hours (0.15 CEUs) of continuing pharmacy education credit.  Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test.   Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
UAN  # 0761-9999-16-191-L02-P

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.

PLATINUM SUPPORTER
ViiV Healthcare

SILVER SUPPORTERS
Bristol-Myers Squibb
Gilead Sciences, Inc
Janssen Therapeutics
Merck & Co, Inc

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at registration“at”iasusa.org or 415-544-9400.

Presenter(s)

Webinar Link

You may view or share the archived recording for educational purposes, however, it is not available for CME credit.